207_Combined course Presentations

First page Table of contents Previous page 532 Next page Last page

GOG 0265

• Phase II study – Persistent or recurrent cervical Ca – One prior line of systemic therapy – 3 doses of ADXS

• 12-month OS = 38.5% in 26 patients

Made with